IL6 and hepatocellular carcinoma: For example, serum IL-6 was an independent risk predictor for HCV-related HCC development in females [28], and reduced serum IL-6 concentration by Estrogens inhibits the diethylnitrosamine (DEN)-induced hepatocarcinogenesis in rodent models [27].